Supar® is the clinically validated blood marker used in hospitals for over twenty years to measure chronic inflammation and predict long-term health. Now available to help you track, optimize, and prove your healthspan trajectory.
CE-IVD certified·Over 1,000,000 suPAR tests performed as of January 2024·Over 1,250 studies as of September 16, 2026
suPAR is released into your bloodstream by activated immune cells. Unlike acute markers like CRP - which fluctuate day to day with every cold and workout - suPAR reflects your stable, baseline level of chronic systemic inflammation. The kind that quietly drives aging.
Your suPAR level is one of the most powerful independent predictors of long-term health outcomes ever identified - for cardiovascular disease, type 2 diabetes, kidney disease, cancer, cognitive decline, and frailty. It tracks how your body is aging, not just how old you are.
Most biomarkers either measure acute states or static traits. suPAR is unusual. Stable enough to give a reliable signal. Modifiable enough to change with how you live. That makes it the rare measurement you can actually use.
Every Supar® test returns three biomarkers - a single, clinically grounded readout of where you stand and how you're trending.
Sample result - three numbers, one trajectory.
Your first suPAR result establishes your baseline - where you stand against population norms for your age, sex, and risk profile. That is useful. But the real power is in the second result. And the third.
Because once you have a baseline, every subsequent measurement is a verdict on what you've done. Cleaner sleep. Better food. Less alcohol. More movement. Smoking cessation. Stress reduction. The literature shows suPAR responds to these interventions - and we built our protocol around serial testing so you can see it happen.
suPAR is a CE-IVD certified clinical biomarker, used in hospital emergency departments and clinics for over twenty years. It is based on the assay Suparnostic® from Virogates A/S. That puts it in a fundamentally different category from methylation tests and wellness assays - when the same assay drives published trials and hospital triage, the number you receive means something real.
See clinical evidence→A test only matters if it can detect change. Most methylation clocks barely move in response to lifestyle interventions. suPAR does: smoking cessation, weight loss, exercise, and reduced alcohol have all been shown to lower it. A measurement that can't reflect change can't guide it.
How suPAR responds to interventions→Over one million suPAR tests performed as of January 2024, and more than 1,250 published studies (PubMed, September 2026) - across cardiovascular, metabolic, kidney, cancer, and infectious disease cohorts spanning hundreds of thousands of patients. Roughly ten times the clinical base of most competing biological age tests.
View the scientific library→Acute markers like high-sensitivity CRP fluctuate with every cold, hard workout, or bad night's sleep. suPAR captures something different: the stable, low-grade inflammation that drives long-term aging - what scientists call inflammaging. Stable enough to trust. Modifiable enough to track.
Why chronic inflammation matters→Most people don't need a panel of two hundred biomarkers. They need one question answered: am I aging on schedule, or faster? suPAR integrates signals across immune, endothelial, metabolic, and organ-level systems - the single measurement with the most predictive power for how long, and how well, you live.
How suPAR integrates whole-body signals→A single number is a snapshot. A trajectory is a strategy. suPAR was designed for serial measurement - reliable, fast, and stable enough that you can test, intervene, and re-test to see whether your trajectory is bending in the right direction.
See a sample longitudinal report→Methylation clocks. Pace-of-aging scores. Glycan profiles. The biological age market has exploded - and most of it has a quiet problem: poor test-retest reliability, weak response to lifestyle change, and almost none of it used in real clinical medicine.
If a measurement of your health can't reliably reflect changes in your health, what is it actually measuring?
We built Supar® on a different premise: a biomarker already clinically validated, already responsive, already in the medical literature.
| - | suPAR® Supar Health | First-generation methylation Horvath / Hannum | Second-generation methylation GrimAge / DunedinPACE | Glycan age GlycanAge |
|---|---|---|---|---|
| Regulatory status | CE-IVD certified clinical assay | Wellness only | Wellness only | Wellness only |
| Used in hospitals | Yes, twenty-plus years | No | No | No |
| Published clinical studies | Over 1,250 (PubMed, September 2026) | High (foundational research) | Moderate to high | Approximately 100 |
| Morbidity hazard ratio T2D, CVD, CKD, cognitive decline, frailty | Highest of any biological age test studied | Modest | Moderate | Moderate |
| Test-retest reliability | High | Moderate | Moderate to high (DunedinPACE) | Moderate |
| Responsive to lifestyle in weeks to months | Yes | Limited | Modest (DunedinPACE) | Yes |
| Turnaround | Days | Weeks | Weeks | Weeks |
| Single-biomarker simplicity | Yes | No (over 800,000 CpG sites) | No | No |
Scroll horizontally on smaller screens. Full citations on the scientific comparison page.
We will be the first to say: the right test depends on the question. For research on cellular aging mechanisms, methylation clocks remain irreplaceable. For tracking your real-world healthspan trajectory - and for proving that your interventions are working - Supar® is the most clinically grounded option available.
suPAR was first described as a clinically relevant biomarker in the early 2000s. It has been studied in over 1,250 published clinical studies (PubMed, September 2026). It has been used in emergency departments across Europe for over a decade for risk-stratification and triage. It has been validated in cohort studies including Inter99, the Copenhagen General Population Study, MESA, and dozens more - covering hundreds of thousands of patients.
We are taking a measurement that the medical literature has converged on as one of the most powerful single biomarkers of long-term health risk - and making it available, accessible, and longitudinal.
A randomized clinical trial across multiple Danish emergency departments evaluating suPAR-guided triage. Established suPAR's role in real-world clinical triage protocols.
A foundational population study (n=4,538) demonstrating that suPAR predicts long-term health outcomes independently of CRP, age, sex, smoking, and lipids.
A Danish population study (Inter99 cohort, n=5,447) tracking lifestyle changes over 5 years. Individuals who improved their diet, increased physical activity, and quit smoking showed significantly lower suPAR levels, and lower suPAR was associated with reduced mortality.
A licensed clinician is part of every Supar® test we offer. Your report is a wellness assessment intended to be reviewed and interpreted within the context of a doctor-patient relationship.
No fifty-page report. No two hundred biomarkers. One clinically validated measurement of how your patient's body is aging, with a trajectory they will return to track.
The Supar® test is sold only to clinics with a qualified clinician. Interpretation, intervention, and follow-up sit where they belong - in the patient-physician relationship you've built.
Because the value of suPAR is in the trajectory, follow-up testing is built into the protocol. That means recurring patient engagement, recurring revenue, and the kind of measurable outcomes that build a clinic's reputation.
The face ages from the outside in - sun, smoke, sleep loss, glycation, alcohol. But it also ages from the inside out. Chronic systemic inflammation is one of the primary upstream drivers of the biological processes that show up as visible aging: collagen degradation, oxidative skin damage, capillary fragility, accelerated epidermal turnover.
Research using established biological aging measures has shown that systemic biological aging tracks closely with visible facial aging. The biology of the face mirrors the biology of the body - and chronic inflammation is the through-line.
Supar® gives aesthetic practitioners a clinical-grade measurement of the systemic inflammatory load that contributes to their patients' visible aging. It complements topical, injectable, and energy-based aesthetic protocols by giving the patient - and the practitioner - an objective way to track whether their lifestyle is supporting their aesthetic outcomes, or quietly undermining them.
Chronic sleep loss elevates systemic inflammation and accelerates visible skin aging.
Heavy use shows up in suPAR before it shows up on the face.
Among the strongest modifiers of both suPAR and dermal collagen quality.
Glycation, oxidative stress, and inflammatory load track together.
"Biological age" is not a clinical endpoint. It is not a measurement of how old your cells are. There is no test - methylation, glycan, blood-based, or otherwise - that can directly read out the age of a biological system.
What biological age tests actually do is take a measurable feature of your body - DNA methylation patterns, glycan profiles, blood biomarker levels - and translate it into an age-equivalent number using a statistical model trained on either chronological age, long-term outcomes, or pace of aging.
The number you receive is a statistical translation of your risk profile. It is useful - sometimes very useful - because it lets you compare your risk trajectory to population norms, and watch whether it improves over time.
But it only matters if the underlying measurement is reliable, the model is rigorously trained, and the endpoint it predicts is one that actually matters: long-term health.
That is why we chose suPAR. Its underlying measurement is among the most analytically stable in the field. Its clinical evidence base is one of the largest of any biomarker. And it is a top-tier predictor of the only endpoint that ultimately matters.
We will never tell you Supar® measures your cellular age. We will tell you it is one of the best ways to quantify, and track, your real long-term health trajectory. We believe that distinction matters.
We've written full, detailed answers to the questions we hear most often - from how Supar® compares to CRP and methylation, to who interprets your result, to where our lab is located. It's an honest, complete account of what this test can and cannot do.
Order your Supar® test, or find a partner clinic near you.
